Biventricular Impella placement via complete venous access
- 22 May 2017
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 93 (6) , E343-E345
Abstract
Impella (Abiomed, Danvers, MA) is an effective option for emergent treatment of critical refractory cardiogenic shock. However, in patients who have inadequate peripheral arterial access, Impella for left ventricular support sometimes requires surgical access, leading to disadvantages for emergent procedures or invasiveness for very sick patients. In addition, Impella for right ventricular support was recently reported to contribute to the management of severe biventricular dysfunction. In this report, we describe a case of refractory cardiogenic shock in a patient with inadequate vascular access who was treated with biventricular Impella via venous and caval-aortic access under conscious sedation. This technique can be used as a bridge to surgical ventricular assist device or heart transplantation.Keywords
This publication has 9 references indexed in Scilit:
- Transcaval Access and Closure for Transcatheter Aortic Valve ReplacementJACC, 2017
- Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP deviceThe Journal of Heart and Lung Transplantation, 2015
- How to perform transcaval access and closure for transcatheter aortic valve implantationCatheterization and Cardiovascular Interventions, 2015
- Impella 5.0 Support in INTERMACS II Cardiogenic Shock Patients Using Right and Left Axillary Artery AccessArtificial Organs, 2015
- 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular CareJACC, 2015
- Caval-Aortic Access to Allow Transcatheter Aortic Valve Replacement in Otherwise Ineligible PatientsJACC, 2014
- Mechanical circulatory support in cardiogenic shockEuropean Heart Journal, 2013
- A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary InterventionCirculation, 2012
- Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trialsEuropean Heart Journal, 2009